Report Highlights
The global electrophoresis market was worth nearly $1.35 billion in 2011 and $1.4 billion in 2012. The market is projected to grow at a compound annual growth rate (CAGR) of 4% over the next five years to reach nearly $1.8 billion by 2018.
Report Includes
- An overview of the global market for electrophoresis, particularly gel electrophoresis (GE) and capillary electrophoresis (CE) technologies
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
- Examination of trends in the following segments: instrumentation, aftermarket supplies, and services
- Discussion of the two major segments, nucleic acid and protein separation
- Descriptions of electrophoresis techniques and technologies used in academia, government research laboratories, and the biopharmaceutical, environmental, chemical, forensics, and food industries
- Coverage of technological issues, including the latest trends and a thorough patent analysis
- Evaluation of the impact of lab-on-a-chip electrophoresis on the overall capillary electrophoresis technology segment
- Comprehensive company profiles of major players.
Report Scope
The study encompasses major technologies of electrophoresis and the various product segments for each technology. The role of electrophoresis as an analytical separation method for both nucleic acid and protein molecules was examined. The major end-user applications for both GE and CE were also included within the scope of this study.
BCC analyzes the impact of the two major electrophoresis techniques on biological molecular separation, determines their current market status, examines their future potential and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. Latest research findings in different industry areas are presented.
BCC presents the industry competitiveness for electrophoresis, technological descriptions and issues, applications, market factors, market potential and revenue forecast projections from 2013 through 2018. Global revenue projections for the electrophoresis market have been developed by the two major technologies and by product segments for every technology. Revenue projections by end-user applications have been included.
BCC also examined the electrophoresis industry by regions and conducted an in-depth study on the competitive landscape for every product segment and the corresponding market share analysis for every technology.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
- The global market for electrophoresis technology increased from $1.2 billion in 2007 to an estimated $1.3 billion by the end of 2008. It should reach $1.6 billion by 2013, a compound annual growth rate (CAGR) of 4.8%.
- Gel electrophoresis now holds a commanding 64% share of the overall market and is expected to be worth $829 million by the end of 2008.
- Capillary electrophoresis technology continues to make inroads in the separation market with estimated revenue of $456 million in 2008.
Related Reports
Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences
The global market for nanoparticle analysis equipment was valued at nearly $5.2 billion in 2011 and is expected to reach $5.3 billion in 2012. Total market value is expected to reach $6.8 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.1%.
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
The global microRNA research tools market was valued at nearly $295.1 million in 2011 and should reach nearly $338.3 million in 2012. Total market value is expected to reach $763 million in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 17.7%.
DNA Sequencing: Emerging Technologies and Applications
The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.
Separation Systems for Commercial Biotechnology
The global market for commercial biotechnology separation systems reached $12.1 billion in 2010, $14.6 billion in 2011, and it will further grow to $26.7 billion at an estimated compound annual growth rate (CAGR) of 12.8% by 2016.
Recent Reports
Major Reverse Osmosis System Components for Water Treatment: The Global Market
The global market for RO system components is expected to grow from $18.8 billion in 2024 and is projected to reach $32.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.2% during the forecast period of 2024 to 2029.
Ultrafiltration Membranes: Technologies and Global Markets
The global market for ultrafiltration membranes was valued at $4.9 billion in 2023. The market is expected to grow from $5.2 billion in 2024 to $8.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Water Filtration: Global Markets
The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $17.4 billion in 2023 to reach $25.7 billion by 2028, at a compound annual growth rate (CAGR) of 8.1% from 2023 through 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More